• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Synthesis and preliminary biological evaluation of 5-substituted-2-(4-substituted phenyl)-1,3-benzoxazoles as a novel class of influenza virus A inhib

tetano

Editor, Senior Moderator
Chem Biol Drug Des. 2012 Jan 27. doi: 10.1111/j.1747-0285.2012.01344.x. [Epub ahead of print]
Synthesis and preliminary biological evaluation of 5-substituted-2-(4-substituted phenyl)-1,3-benzoxazoles as a novel class of influenza virus A inhibitors.
Li Z, Zhan P, Naesens L, Vanderlinden E, Liu A, Du G, De Clercq E, Liu X.
Source

Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, 44, West Culture Road, 250012, Jinan, Shandong, P.R.China. Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050, China.
Abstract

The diversity-oriented chemistry synthesis together with the random screening approach has permitted the discovery and optimization of novel antiviral lead compounds. In this paper, a series of novel 5-substituted-2-(4-substituted phenyl)-1,3-benzoxazoles was synthesized and evaluated for their in vitro anti-influenza A virus (IFV-A) and anti-influenza B virus (IFV-B) activity. The activity was monitored by the MTS assay in the Madin-Darby canine kidney (MDCK) cells. Compound 7h showed excellent inhibitory activity and selective index against A/H3N2 (EC(50) = 37.03 μM, SI>5), which were all higher than that of the reference drug Oseltamivir (EC(50) >59.00 μM, SI>1). However, no compound displays inhibitory activity against influenza B virus. ? 2012 John Wiley & Sons A/S.

? 2012 John Wiley & Sons A/S.

PMID:
22284752
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22284752
 
Back
Top Bottom